Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00267501 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv21
  2. Site contact updatedv20
  3. 5 versions Re-verified since Nov 10, 2015, no change to tracked fieldsv15-v19
  4. Lead sponsor: Marc Rothenberg to Children's Hospital Medical Center, Cincinnativ14
  5. Enrollment target: 500 to 5000
    • Primary and study completion dates: Jan 2050
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Lead sponsor: Children's Hospital Medical Center, Cincinnati to Marc Rothenbergv12
  2. Eligibility criteria shortened, about 108 words
    • Collaborators shortened, about 5 words
    v11
  3. 3 versions Re-verified since Dec 24, 2008, no change to tracked fieldsv8-v10
  4. Study title expanded, about 2 wordsv7
  5. 5 versions Re-verified since Dec 28, 2005, no change to tracked fieldsv2-v6
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
Trial Details
NCT Number NCT00267501
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions
(from sponsor)		 Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, Food Allergy
Related terms Eosinophilia, Food Hypersensitivity
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov